Corporate News 21-Dec-21
Board of Chalet Hotels approves issuance of NCDs up to Rs 375 cr
At meeting held on 21 December 2021
The Board of Chalet Hotels at its meeting held on 21 December 2021 has approved the offer of Secured, Unlisted, Non cumulative, Redeemable and Non-Convertible Debentures upto an amount of Rs.375 crore to 'International Finance Corporation' on a Private Placement basis.
Previous News
Chalet Hotels reports consolidated net profit of Rs 102.34 crore in the December 2022 quarter
( Results - Announcements 24-Jan-23 15:02 )
ICRA upgrades rating of Chalet Hotels; revises outlook to 'positive'
( Hot Pursuit - 11-Jul-23 12:28 )
Chalet Hotels completes acquisition of The Dukes Retreat
( Corporate News - 24-Mar-23 09:11 )
Board of Chalet Hotels approves acquisition of Mahananda Spa and Resorts
( Corporate News - 10-Feb-25 19:52 )
Volumes soar at Marico Ltd counter
( Hot Pursuit - 07-May-24 14:30 )
Chalet Hotels completes acquisition of ‘The Dukes Retreat' at Khandala
( Corporate News - 24-Mar-23 09:15 )
Chalet Hotels acquires 158-room Courtyard by Marriott Aravali Resort, NCR
( Corporate News - 01-Mar-24 10:01 )
Chalet Hotels reports consolidated net profit of Rs 15.73 crore in the September 2022 quarter
( Results - Announcements 22-Oct-22 08:02 )
Chalet Hotels IPO subscribed 7%
( IPO Centre - IPO News 29-Jan-19 18:04 )
Chalet Hotels Limited: Ratings reaffirmed, and negative outlook retained; rated amount
( Press Releases - 19-Jul-21 11:23 )
Chalet Hotels to announce Quarterly Result
( Corporate News - 01-Jun-20 13:58 )
Other Stories
LMW schedules board meeting
03-Jul-25 09:15
Julien Agro Infratech announces board meeting date
03-Jul-25 09:15
Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
03-Jul-25 09:15
Shriram Asset Mgt. Company schedules AGM
03-Jul-25 09:14
Ideaforge Technology to convene AGM
03-Jul-25 09:14
D-Link (India) to announce Quarterly Result
03-Jul-25 09:14
Tuni Textile Mills to conduct board meeting
03-Jul-25 09:14
Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
03-Jul-25 09:12
Shakti Pumps launches QIP issue
03-Jul-25 09:08
Jai Mata Glass to conduct board meeting
02-Jul-25 19:12
Back
Top
